Hepatitis treatment with carbostyril compounds

Details Hepatitis treatment with carbostyril compounds Hepatitis treatment with carbostyril compounds

1995-06-06

1996-08-06

Treavers, Russell

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

A61K 31495

Patent

active

055434126

ABSTRACT:
An object of the invention is to provide hepatitis therapy. According to the invention, an apoptosis regulating composition is provided which comprises, as an active ingredient, at least one carbostyril derivatives of general formula (1) ##STR1## and salts thereof.

REFERENCES:
patent: 4415572 (1983-11-01), Tominaga et al.
Sasayama et al, Heart and Vessels, 2(1): 23-28 (1986).
Lueprasitsakul et al, Endocrinology, 128(6): 2709-2714 (1991).
Berkow, The Merck Manual of Diagnosis and Therapy, Merck Sharp & Dohme Research Laboratories, Rahway, N.J., pp. 1043-1050 (1987).
Bush et al, Experimental Hematology, 19(6): 490 (1991).
Nakai et al, Biomedicine and Pharmacotherapy, 46(5-7): 308 (1992).

Affiliated with

Also associated with

Rating

Hepatitis treatment with carbostyril compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hepatitis treatment with carbostyril compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatitis treatment with carbostyril compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2191233